NOMAD Power Solutions, Inc. (NasdaqCM: NMAD)
Health Care · Biotechnology · US
$4.22
+4.20% today · +6.0% 1Y
NOMAD Power Solutions, Inc. (NasdaqCM: NMAD) operates in the Biotechnology industry within the Health Care sector. The company is valued at $65.21M and employs 3 people.
Over the last twelve months the share price has gained 6.0%, trading between 2.36 and 8.38.
NMAD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $65.21M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 1.33
- 52-week high
- $8.38
- 52-week low
- $2.36
- Avg volume (3M)
- —
- Shares outstanding
- 16.10M
- Employees
- 3
- Next earnings
- —
About NOMAD Power Solutions, Inc.
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Boca Raton, FL.
- ISIN
- US5393193017
- Founded
- 2020
- Listed since
- Nov 24, 2020
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $261.53 | -1.60% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $440.95 | -0.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $147.78 | -0.67% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $548.74 | -0.74% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $827.02 | -0.78% |
| argenx SEENXTBR: ARGX | $64.17B | €895.40 | +1.84% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $155.61 | -2.03% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.